Market revenue in 2023 | USD 460.9 million |
Market revenue in 2030 | USD 786.2 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | BD, Danaher Corp, Koninklijke Philips NV, Qiagen NV, Thermo Fisher Scientific Inc, Myriad Genetics Inc, Argon Medical Devices, Roche Holding AG ADR, Hologic Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.16% in 2023. Horizon Databook has segmented the Spain breast cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, under the law of Cohesion and Quality of the Spanish National Health System, new diagnostics are added to the national catalogue only after a thorough review of their effectiveness, efficacy, efficiency, & safety. The National Health System’s International Council presides over the inclusion of services and products, while the central government is responsible for pricing.
Breast cancer diagnostic instruments and service providers are introducing novel technologies with improved accuracy, speed, & sensitivity. Genetic testing coupled with advanced diagnostic devices is an essential part of clinical diagnosis. The Spanish breast cancer diagnostics market is still in its premature stage.
In addition, increasing mortality due to breast cancer is considered to be another factor boosting market growth. Novel Spanish startup formed in 2020, Reveal Genomics, aims at developing genetic tests to facilitate the breast cancer treatment. Initially, the company was focused on metastatic breast cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain breast cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Spain breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account